Top 10 Pediatric Vaccines Market by Revenue, Sale and Market Demand - Global Forecast to 2023

Global Pediatric Vaccines Market report examines the market position and viewpoint of the market globally, from various angles, such as key players, geological regions, types of diseases and technology. And also cover the other information such as Pediatric Vaccines Market trends, Top players, chapter-wise Description followed by various user perceptions and Forecast till 2023.

Market Highlights

The vaccines administered to prevent children from several non-infectious and infectious diseases are known as pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause a disease. Moreover, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus. Thus, they assist the immune system in protecting itself from infectious or non-infectious diseases in the future. Currently, immunization prevents an estimated 2-3 million deaths every year. Furthermore, about 1.5 million deaths can be prevented through improved global coverage for vaccination.

There are different pediatric vaccines accessible in the market, for example, pneumococcal immunization, polio antibody, rotavirus immunization, MMR immunization, flu immunization, hepatitis B antibody, meningococcal immunization, and Hib antibody. There has been constant research for the development of novel molecules providing immunity against fatal diseases such as Zika virus and different types of cancers. For instance, in June 2016, Inovio Pharmaceuticals, Inc. stated the commencement of phase I clinical trial for their Zika DNA vaccine named GLS-5700.
The increasing collaboration of local manufacturers with key players to deliver high-quality vaccines in remote areas, increasing economic growth, global initiative undertaken by key players in developing innovative vaccines, increasing government support, increasing awareness regarding benefits of vaccination in prevention of diseases, and favorable reimbursement are the major factors expected to fuel the global pediatric vaccines market over the forecast period.
However, low accessibility to remote areas, increasing availability of biosimilars at low rates, increasing cost of vaccines, limited or no access to healthcare services in developing and under-developed countries, low healthcare spending, and less medical coverage for pediatric vaccination are some of the challenges which might hamper the growth of the global pediatric vaccines market in future. Global market for pediatric vaccines is expected to grow at a CAGR of approximately 10.6% during 2017 to 2023.

Get Exclusive Report Sample Here - https://www.marketresearchfuture.com/sample_request/5779

Key Players in Pediatric Vaccines Market

GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), Grifols (Spain), Crucell (Netherlands), Bharat Biotech (India), Kaketsuken (U.S.), Panacea Biotec (India), Baxter International (U.S.), Zydus Cadila (India), Nuron (U.S.), S K Chemicals (South Korea), Dynavax Technologies (U.S.), Bharat Immunologicals and Biologicals (India), Lupin Pharmaceuticals, Inc. (India), Indian Immunologicals (India), Novartis AG (Switerzland), LG Life Sciences (India), Shenzhen Kangtai Biological Products (China), Sinovac Biotech (China), Bio Med (India), AstraZeneca (UK), bioCSL Inc. (U.S.), Valeant Pharmaceuticals (U.S.), Takeda Pharmaceutical (Japan), and others.

Pediatric Vaccines Market: Segmentation

The global pediatric vaccines market has been segmented on the basis of type, technology, disease indication, and route of administration. On the basis of type, the global pediatric vaccines market is segmented into monovalent vaccines, multivalent vaccines, and others. On the basis of technology, the global pediatric vaccines market is segmented into synthetic vaccines, dendritic cells vaccines, conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, and others. On the basis of disease indication, the global pediatric vaccines market is segmented into MMR (Measles, Mumps, and Rubella), polio, Haemophilus influenza type B, pneumococcal disease, meningococcal disease, influenza, DTP (Diphtheria, Tetanus, Pertussis), hepatitis, varicella, rotavirus, combination vaccines, and others. On the basis of route of administration, the global pediatric vaccines market is segmented into intramuscular administration, subcutaneous administration, oral administration, and other routes of administration

Pediatric Vaccines Market: Regional Analysis

The global pediatric vaccines market consists of four regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region accounted for the largest market share of the global pediatric vaccines market owing to the growing initiatives by the U.S. Department of Health and Human Services (HHS) to reduce the occurrence rate of infectious diseases. Such factors along with the growing immunization will fuel the U.S. market.

The European pediatric vaccines market is urged due to the superior government spending such as NHS (Nation Healthcare Service) for the development of the pharmaceutical and medical industries. The Asia Pacific region is expected to grow rapidly during the forecast period owing to the growing healthcare sector in leading regions such as China and India. The Middle Eastern region is expected to grow at a steady pace owing to factors such as rising R&D activities in the healthcare sector and extensive development of healthcare infrastructure.

TABLE OF CONTENT

1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Pediatric Vaccines Market, By Technology
6 Global Pediatric Vaccines Market, By Disease Indication
7 Global Pediatric Vaccines, By Route of Administration
8 Global Pediatric Vaccines, By Region
9 Global Pediatric Vaccines, By End-User
10 Global Pediatric Vaccines Market, By Region
11 Competitive Landscape
12 Company Profile
13 MRFR Conclusion

LIST OF TABLES

Table 1 Pediatric Vaccines Industry Synopsis, 2017–2023
Table 2 Pediatric Vaccines Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Pediatric Vaccines Market, By Region, 2017–2023, (USD Million)
Table 4 Pediatric Vaccines Market, By Type, 2017–2023, (USD Million)
Table 5 Pediatric Vaccines Market, By Technology, 2017–2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process
Figure 2 Segmentation for Pediatric Vaccines Market
Figure 3 Segmentation Market Dynamics for Pediatric Vaccines Market
Figure 4 Global Pediatric Vaccines Market Share, By Type, 2017
Figure 5 Global Pediatric Vaccines Market Share, By Technology, 2017

Browse Complete 100 Pages Premium Research Report Enabled with 84 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/pediatric-vaccines-market-5779

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office №528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune — 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.